|
|
Article: Clinic Roundup.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Basilea Pharmaceutica Ltd., of Basel, Switzerland, reported Phase III results showing that patients with severe chronic hand eczema can benefit from re-treatment with alitretinoin. In two previous randomized clinical trials, alitretinoin was found to be effective in treating severe chronic hand eczema in patients refractory to topical treatments, and the latest trial demonstrated that patients responsive to initial treatment with alitretinoin also can benefit from additional treatment courses after eventual disease recurrence. The safety profile of alitretinoin observed in this study was consistent with previous trials, and the new data will be integrated into regulatory ...